NCT03744702View on ClinicalTrials.gov

Impact of Ascorbic Acid Treatment on the Development and Treatment of Vasodilation in Cardiac Surgery

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

June 28, 2019

Primary Completion Date

February 5, 2021

Study Completion Date

February 5, 2021

Conditions
Vasoplegia
Interventions
DRUG

Ascorbic Acid

Patients will receive IV ascorbic acid.

Trial Locations (1)

55905

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT03744702 - Impact of Ascorbic Acid Treatment on the Development and Treatment of Vasodilation in Cardiac Surgery | Biotech Hunter | Biotech Hunter